9/27
Penn in the News
A round-up of Penn mentions in local, national, and international media.
Filter Stories
Displaying 1 - 10 of 12451
Penn In the News
Stop the doom. We failed to prevent climate change—but we will decide how bad it’ll get
In an Op-Ed, Michael Mann of the School of Arts & Sciences says that climate doom and denial can lead people down a path of disengagement, benefiting fossil fuel interests that profit from climate inaction.
Penn In the News
Earth’s ‘fragile moment’ with Michael Mann, latest on Irizarry police shooting
Michael Mann of the School of Arts & Sciences discusses what can be done to slow the warming of the planet and the politics that get in the way.
Penn In the News
What to know about Paxlovid rebound
E. John Wherry of the Perelman School of Medicine says that it’s hard to get real-world data on COVID treatments because many people who have a rebound are unlikely to tell their doctors.
Penn In the News
An overdose drug is finally over-the-counter. Is that enough to stop the death toll?
Shoshana Aronowitz of the School of Nursing says that over-the-counter Narcan is a baby step in the right direction, not a game changer.
Penn In the News
Your wrist could give clues to future health
A study by Carsten Skarke of the Perelman School of Medicine and colleagues finds that wrist temperature is associated with the risk of future disease.
Penn In the News
What Amazon’s up to $4B commitment to Anthropic could mean for AI space
Chris Callison-Burch of the School of Arts & Sciences comments on how investing in artificial intelligence is a strategic move.
Penn In the News
Do bats get cancer? Plus, how your wrists could give clues to future health, and more health news
Carsten Skarke of the Perelman School of Medicine comments on a new study that indicates wrist temperature is associated with future risk of disease.
Penn In the News
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
Holly Fernandez Lynch of the Perelman School of Medicine says that lowered FDA standards send a message to the drug industry that they don’t have to prove their medication works.
Penn In the News
Sex for 62 to 72-year-olds could help prevent dementia, study shows
The research of Mike Cirigliano of the Perelman School of Medicine confirms sexual activity is a form of physical exercise.
Penn In the News
What happens when you stop taking Ozempic? Doctors explain the long- and short-term effects
Jena Shaw Tronieri of the Perelman School of Medicine explains why missing a dose of Ozempic is no reason to panic.